|
🐜
|
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
27 auth.
C. Orkin,
K. Arastéh,
M. Górgolas Hernández-Mora,
V. Pokrovsky,
E. Overton,
P. Girard,
S. Oka,
S. Walmsley,
Christopher Bettacchi,
C. Brinson,
P. Philibert,
Johan J. Lombaard,
M. S. St. Clair,
H. Crauwels,
S. L. Ford,
...
P. Patel,
Vasiliki Chounta,
R. D'Amico,
S. Vanveggel,
D. Dorey,
A. Cutrell,
Sandy Griffith,
D. Margolis,
P. Williams,
W. Parys,
Kimberly Smith,
W. Spreen
|
7 |
2020 |
7
🐜
|
|
🐜
|
Immunologic and virologic evaluation after influenza vaccination of HIV‐1‐infected patients
9 auth.
K. Fowke,
R. D'Amico,
D. Chernoff,
J. Pottage,
C. Benson,
B. Sha,
...
H. Kessler,
A. Landay,
G. Shearer
|
7 |
1997 |
7
🐜
|
|
🐜
|
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.
27 auth.
C. Orkin,
S. Oka,
P. Philibert,
C. Brinson,
A. Bassa,
D. Gusev,
O. Degen,
J. García,
E. Morell,
D. Tan,
R. D'Amico,
D. Dorey,
Sandy Griffith,
S. Thiagarajah,
M. S. St. Clair,
...
R. V. Van Solingen-Ristea,
H. Crauwels,
S. Ford,
P. Patel,
V. Chounta,
S. Vanveggel,
A. Cutrell,
V. van Eygen,
Kati Vandermeulen,
D. Margolis,
Kimberly Smith,
W. Spreen
|
6 |
2021 |
6
🐜
|
|
🐜
|
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
36 auth.
G. Rizzardini,
E. Overton,
C. Orkin,
S. Swindells,
K. Arastéh,
M. Górgolas Hernández-Mora,
V. Pokrovsky,
P. Girard,
S. Oka,
J. Andrade-Villanueva,
G. Richmond,
A. Baumgarten,
M. Masiá,
G. Latiff,
Sandy Griffith,
...
Conn M. Harrington,
Krischan J. Hudson,
M. S. St. Clair,
C. Talarico,
P. Patel,
A. Cutrell,
V. van Eygen,
R. D'Amico,
J. Mrus,
Sterling Wu,
S. Ford,
Ken Chow,
Jeremy N Roberts,
Angela Wills,
Nicola Walters,
S. Vanveggel,
R. V. Van Solingen-Ristea,
H. Crauwels,
Kimberly Smith,
W. Spreen,
D. Margolis
|
6 |
2020 |
6
🐜
|
|
🐢
|
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study.
20 auth.
C. Orkin,
E. Bernal Morell,
D. Tan,
H. Katner,
H. Stellbrink,
E. Belonosova,
R. Demoor,
Sandy Griffith,
S. Thiagarajah,
R. V. Van Solingen-Ristea,
...
S. Ford,
H. Crauwels,
P. Patel,
A. Cutrell,
Kimberly Smith,
Kati Vandermeulen,
E. Birmingham,
M. S. St. Clair,
W. Spreen,
R. D'Amico
|
6 |
2021 |
6
🐢
|
|
🐜
|
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure
23 auth.
C. Orkin,
J. Schapiro,
C. Perno,
D. Kuritzkes,
P. Patel,
R. Demoor,
D. Dorey,
Yongwei Wang,
Kelong Han,
V. van Eygen,
...
H. Crauwels,
S. L. Ford,
Christine L Latham,
M. S. St. Clair,
J. Polli,
S. Vanveggel,
Kati Vandermeulen,
R. D'Amico,
H. Garges,
A. Zolopa,
W. Spreen,
J. van Wyk,
A. Cutrell
|
6 |
2023 |
6
🐜
|
|
🐜
|
Effect of Ritonavir/Saquinavir on Stereoselective Pharmacokinetics of Methadone: Results of AIDS Clinical Trials Group (ACTG) 401
12 auth.
J. Gerber,
S. Rosenkranz,
Yoninah Segal,
J. Aberg,
R. D'Amico,
D. Mildvan,
...
R. Gulick,
Valery Hughes,
C. Flexner,
F. Aweeka,
A. Hsu,
J. Gal
|
5 |
2001 |
5
🐜
|
|
🦁
|
Lower CD4+ T Lymphocyte Nadirs May Indicate Limited Immune Reconstitution in HIV-1 Infected Individuals on Potent Antiretroviral Therapy: Analysis of Immunophenotypic Marker Results of AACTG 5067
10 auth.
R. D'Amico,
Yijun Yang,
D. Mildvan,
S. Evans,
C. Schnizlein-Bick,
R. Hafner,
...
N. Webb,
M. Basar,
R. Zackin,
M. Jacobson
|
5 |
2005 |
5
🦁
|
|
🐜
|
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study
25 auth.
E. Overton,
G. Richmond,
G. Rizzardini,
A. Thalme,
P. Girard,
Alexander Wong,
N. Porteiro,
S. Swindells,
J. Reynes,
S. Noe,
Conn M. Harrington,
C. M. Español,
Carolina Acuipil,
Asma Aksar,
Yuanyuan Wang,
...
S. L. Ford,
H. Crauwels,
V. van Eygen,
R. V. Van Solingen-Ristea,
Christine L Latham,
S. Thiagarajah,
R. D'Amico,
Kimberly Smith,
Kati Vandermeulen,
W. Spreen
|
5 |
2023 |
5
🐜
|
